In Vitro Additive Effect of Polymyxin B and Rifampin Against Serratia marcescens
Open Access
- 1 June 1975
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 7 (6) , 874-876
- https://doi.org/10.1128/aac.7.6.874
Abstract
The combination of polymyxin B and rifampin resulted in an additive effect against all 12 clinical isolates of Serratia marcescens examined, including multiple-drug-resistant isolates.Keywords
This publication has 9 references indexed in Scilit:
- Evaluation of Different Antibiotic Actions Combined with RifampicinChemotherapy, 1975
- Studies on group A (phage tail) bacteriocins of Serratia marcescens. IV. Preliminary characterization of receptors of subgroup II bacteriocins.1974
- In Vitro Studies of BB-K8, a New Aminoglycoside AntibioticAntimicrobial Agents and Chemotherapy, 1973
- MICROBIOLOGICAL EVALUATION OF BB-K 8, A NEW SEMISYNTHETIC AMINOGLYCOSIDEThe Journal of Antibiotics, 1972
- Characterization of an unusual strain of proteus rettgeri associated with an outbreak of nosocomial urinary-tract infection.1971
- Susceptibility of Pseudomonas aeruginosa to carbenicillin.1970
- The Synergistic Action of the Sulfonamides and the Polymyxins against Serratia marcescensThe Journal of Infectious Diseases, 1970
- Antibiotic susceptibility testing by a standardized single disk method.1966
- Synergism between sulphonamide drugs and antibiotics of the polymyxin group againstProteus sp. in vitroJournal of Clinical Pathology, 1963